Coya Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Arun Swaminathan, with a market cap of $110.5M.
Based on Q1 2026 filing
Common questions about Coya Therapeutics, Inc.
Coya Therapeutics, Inc. (COYA) has a market capitalization of $110.5M and trades on NASDAQ.
Coya Therapeutics, Inc. has approximately 6 employees.